The Potential of AI-Driven Speech Biomarkers in Mental Health Assessment
By
Hamilton Morrin
Matthew M. Nour
June 25, 2026
Clinical Scorecard: The Potential of AI-Driven Speech Biomarkers in Mental Health Assessment
At a Glance
Category Detail
Condition Psychosis
Key Mechanisms Computational analysis of speech capturing acoustic, semantic, syntactic, and sentiment features.
Target Population Individuals with schizophrenia spectrum disorders and acute care inpatients with psychotic disorders.
Care Setting Clinical assessment and monitoring of psychotic symptoms.
Key Highlights
Automated speech analysis can provide contemporaneous estimations of psychotic symptom severity. Longitudinal data enhances the tracking of symptom change markers. Negative symptom-related speech features show potential for clinical translation.
Guideline-Based Recommendations
Diagnosis
Utilize speech markers for assessing psychotic symptom severity.
Management
Integrate speech analysis outputs with clinical assessments for monitoring.
Monitoring & Follow-up
Implement scalable, low-burden speech tasks for frequent monitoring.
Risks
Consider extraneous factors like medication that may influence speech characteristics.
Patient & Prescribing Data
Patients with psychotic disorders.
Speech analysis may complement routine clinical reviews and help identify deviations from baseline.
Clinical Best Practices
Ensure interpretability of prediction models to enhance clinical trust. Calibrate prediction outputs to actionable clinical responses. Prioritize data governance and patient privacy in speech data handling.
Related Resources & Content